Search

everythinglearnresearchcommunity

for

Search:↓

Chronic telogen effluvium is a condition where there is prolonged shedding of hair.

Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.

Hair follicle counts and ratios are helpful in diagnosing hair loss types, but should be used with other specific features for accurate diagnosis.

The supplement effectively improved hair growth and reduced hair loss safely.

Dermoscopic features can help distinguish female androgenetic alopecia from telogen effluvium and healthy controls.

Early diagnosis and personalized treatment are crucial for managing hair loss in India.

AGA and TE can be differentiated by specific trichoscopic features, with AGA showing more variation in hair thickness in fronto-temporal areas.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

A woman's sudden hair loss was linked to her previous COVID-19 infection.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Older female squirrel monkeys often experience a type of hair loss similar to chronic telogen effluvium in humans.

CTE and FPHL are different hair loss types with unique causes.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Hair in the front part of the scalp is more likely to fall out than hair in the back in acute telogen effluvium.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

COVID-19 infection can significantly cause temporary hair loss.

Chronic telogen effluvium is a common hair loss condition with specific characteristics and treatment options.

Critically ill patients may experience temporary hair loss after a fever.

Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.